Loading formats...
FDA Pulls Emergency Authorization For Hydroxychloroquine
W
Wochit Business
5 views • Jun 15, 2020
Description
It's the end of the road for a COVID-19 treatment once heralded as a “game changer” by Trump.
The FDA has revoked its emergency use authorization of hydroxychloroquine and chloroquine.
This is after a review of the evidence showed both drugs are likely ineffective against the virus.
Initially, doctors were allowed to prescribe it for COVID-19 despite it not being approved for that use.
Early studies suggested the drug could affect the coronavirus’s ability to replicate.
Now that allowance has been removed and it is no longer a plan of treatment, says Gizmodo.
The FDA has revoked its emergency use authorization of hydroxychloroquine and chloroquine.
This is after a review of the evidence showed both drugs are likely ineffective against the virus.
Initially, doctors were allowed to prescribe it for COVID-19 despite it not being approved for that use.
Early studies suggested the drug could affect the coronavirus’s ability to replicate.
Now that allowance has been removed and it is no longer a plan of treatment, says Gizmodo.
Discover more
More from this user
01:04
Are you a pillow princess?
Wochit Business
01:05
COVID-19: Child under 10 becomes the youngest Australian to die
Wochit Business
01:03
Woman born with no womb gives birth to two children
Wochit Business
01:06
Was Meghan boring on the Ellen show on purpose?
Wochit Business
01:07
This is why the Queen's hands are purple in the recent photograph
Wochit Business
01:03
UPSKIRTING DELIVEROO RIDER
Wochit Business
Related videos
00:37
FDA Pulls Emergency Authorization For Hydroxychloroquine
Wochit Entertainment
00:37
FDA Pulls Emergency Authorization For Hydroxychloroquine
Wochit Tech
00:37
FDA Pulls Emergency Authorization For Hydroxychloroquine
Wochit
00:45
U.S. FDA revokes emergency use authorization of hydroxychloroquine as COVID-19 drug
Arirang News
01:12
【 Investment Promotion · two thousand twenty-four fourteenth ANDA in the United States 】 Puli Pharmaceutical - Cyclophosphamide for Injection Obtained Marketing Authorization from the US Food and Drug Administration (FDA)
DTnewswire dongtaibao888
00:29
FDA Pulls Infant Formula from Shelves Due to Lack of Evaluation
Benzinga